India and South Africa demand waiver of certain provisions of Intellectual Property for Covid-19 therapeutics
This statement comes at a time when the race for Covid-19 vaccine is heating up across the world. Though most vaccine makers have received government funding to develop Covid-19 vaccines companies have remained firm that they won ’t be giving up patents or the IP of these vaccines.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: African Health | Biotechnology | COVID-19 | Funding | Government | India Health | Pharmaceuticals | South Africa Health | Vaccines